4Bridges CB. Prevention and Control of influenza Recommendations of the ACIP[J]. MMWR,Recomn Rep,2002,51(RR-3):1-31.
5Keitel WA, Cate TR, Couch RB, et al. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period[J]. Vaccine, 1997,15(10): 1114-1122.
6Cavdar C, Sayan M, Sifil A, et al. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients [J]. Scand J Urol Nephrol,2003,37(1):71-76.
7Morales A, Arias Salazar J, Salazar Y, et al. A randomized controlled trial comparing split and subunit influenza vaccines in adults in Colombia[J]. Medicina(B Aires),2003,63(3): 197-204.
8Ruben FL. Inactivated influenza virus vaccines in children [J]. Clin Infect Dis,2004,38(5) :678-688.
9Castro M, Dozor A, Fish J, et al. The safety of inactivated influenza vaccine in adults and children with asthma [J]. N Engl J Med,2001,345(21): 1529-1536.
1Yamaguehi H, Kawai H, Matsumoto T, et al. Post marketing surveillance of the safety of levofloxacin in Japan[ J]. Chemo- therapy, 2007,53 (2) :85- 103.
3Galatti L, Giustini SE , Sessa A, et al. Neuropsychiatric re- actions to drugs: an analysis of spontaneous reports from gen- eral practitioners in Italy[J]. Pharmaol Res, 2005,51 (3) : 211- 216.
4Fish DN. Fluoroquinolonc adverse effects and drug interac- tions[ J]. Pharmacotherapy,2001,21 ( 10 Pt 2) : 253- 272.
5Reeves RR Exacerbation of psychotic symptoms associated with gatifloxacin[ J]. Psychosomatics, 2007,48 ( 1 ) :87.
